Wael Massrieh, VP of Scientific Affairs at Neptune Technologies and Bioressources (NASDAQ: NEPT), which develops and commercializes Neptune Krill Oil, discusses why his company is one of the most diverse and nearly de-risked investments in the healthcare space.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…